381 related articles for article (PubMed ID: 24968121)
21. Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis.
Zhao QT; Zhang XP; Zhang H; Duan GC
Oncotarget; 2017 Dec; 8(67):112085-112093. PubMed ID: 29340113
[TBL] [Abstract][Full Text] [Related]
22. The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis.
Cao W; Yao X; Cen D; Zhi Y; Zhu N; Xu L
BMC Gastroenterol; 2020 Jan; 20(1):16. PubMed ID: 31959103
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.
Zhang X; Zhao W; Yu Y; Qi X; Song L; Zhang C; Li G; Yang L
World J Surg Oncol; 2020 Jul; 18(1):191. PubMed ID: 32731872
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
Ma W; Zhang P; Qi J; Gu L; Zang M; Yao H; Shi X; Wang C; Jiang Y
Sci Rep; 2016 Oct; 6():35378. PubMed ID: 27739490
[TBL] [Abstract][Full Text] [Related]
25. Inverse Association between Platelet-Lymphocyte Ratio and Prognosis in Terminally Ill Cancer Patients: A Preliminary Study.
Lee Y; Kim YW; Park DK; Hwang IC
J Palliat Med; 2017 May; 20(5):533-537. PubMed ID: 27858496
[TBL] [Abstract][Full Text] [Related]
26. Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer.
Zhu Y; Si W; Sun Q; Qin B; Zhao W; Yang J
Oncotarget; 2017 Jan; 8(1):1023-1030. PubMed ID: 27906679
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer.
Kim SH; Lee HW; Go SI; Lee SI; Lee GW
Oncotarget; 2016 Jun; 7(24):36198-36206. PubMed ID: 27105529
[TBL] [Abstract][Full Text] [Related]
28. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
29. Elevated platelet lymphocyte ratio is a poor prognostic factor in advanced epithelial ovarian cancer.
Chon S; Lee S; Jeong D; Lim S; Lee K; Shin J
J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101849. PubMed ID: 32619726
[TBL] [Abstract][Full Text] [Related]
30. Preoperative Platelet to Lymphocyte Ratio as a Prognostic Factor for Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Riauka R; Ignatavicius P; Barauskas G
Dig Surg; 2020; 37(6):447-455. PubMed ID: 32690855
[TBL] [Abstract][Full Text] [Related]
31. Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: Meta-analysis.
Takenaka Y; Oya R; Kitamiura T; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A
Head Neck; 2018 Dec; 40(12):2714-2723. PubMed ID: 30102821
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score in patients with breast cancer: A prognostic nomogram study.
Zheng Y; Wu C; Yan H; Chen S
Clin Chim Acta; 2020 Jul; 506():110-121. PubMed ID: 32156604
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
Zhao Y; Si G; Zhu F; Hui J; Cai S; Huang C; Cheng S; Fathy AH; Xiang Y; Li J
Oncotarget; 2017 Apr; 8(14):22854-22862. PubMed ID: 28206965
[TBL] [Abstract][Full Text] [Related]
35. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers.
Du Y; Zhou X; Huang Z; Qiu T; Wang J; Zhu W; Wang T; Liu P
PLoS One; 2014; 9(10):e110182. PubMed ID: 25333693
[TBL] [Abstract][Full Text] [Related]
37. The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis.
Li DY; Hao XY; Ma TM; Dai HX; Song YS
Sci Rep; 2017 Nov; 7(1):15387. PubMed ID: 29133845
[TBL] [Abstract][Full Text] [Related]
38. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
[TBL] [Abstract][Full Text] [Related]
39. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]